Anticancer Therapies – Products
Product News
YM BioSciences Provides Update on the Development Program for Nimotuzumab
Eleven abstracts on nimotuzumab to be presented at ASCO.
Product News
Thermo Scientific Introduces New Capabilities for Comprehensive Qualitative and Quantitative Proteomics at ASMS 2011
Integrated capabilities offer deeper, broader understanding of proteomes and biological pathways.
Product News
Benitec’s Gene Silencing Technology Used by Johns Hopkins’ Scientists in the Development of a Treatment for Radio-Resistant Prostate Cancer
Researchers in the US used a form of Benitec’s ddRNAi as a key component of their therapeutic molecule in preclinical studies both in vitro and in vivo.
Product News
RPC to Exhibit Onko-Sure® Cancer Test at the ASCO Annual Meeting
Marks RPC's 3rd medical conference participation this year.
Product News
Cytheris and CITN Announce Selection of Recombinant Interleukin-7 (CYT107) for Initial Studies at Member Institutions
Network consists of 27 institutions with the goal of making effective immunotherapy agents broadly available for treatment of cancer.
Product News
Cytheris, Centre Léon Bérard and ImmunID Announce Initiation of Clinical Trial to Evaluate Combination Regimen of IL-7 and XELODA® in Treatment of Metastatic Breast Cancer
Phase IIa study will investigate the optimal schedule for delivery of CYT107 and its ability to prevent or reverse the effects of chemotherapy-induced lymphopenia characterized by a low CD4 T cell count, identified as an independent prognostic factor for overall survival in patients with advanced cancers.
Product News
Roche’s RTCA HT Instrument Adapts Real-Time Cell Analysis to a High-Throughput Format
RTCA HT Instrument´s design allows for integration with automated plate and liquid handling systems.
Product News
Oncodesign Offers World’s Most Comprehensive Collection of Patient-derived Colorectal Tumor Models
Collection of 53 models offers full range of characterization.
Product News
PRECOS and Argenta Extend Collaboration to Offer World Class Integrated Oncology Drug Discovery Services
The five-year extension of the alliance will allow both companies to offer unrivalled expertise in cancer research to their pharmaceutical clients.
Product News
Peregrine Announces Initiation of Lung Cancer Investigator-Sponsored Trial
Targeted antibody bavituximab to be evaluated in combination with pemetrexed and carboplatin for front-line non-small cell lung cancer.
Advertisement
